ESMO Hot Topics Update: New Developments in Precision Diagnosis and Treatment with Talazoparib

ESMO Hot Topics Update: New Developments in Precision Diagnosis and Treatment with Talazoparib

At this year's recently concluded ESMO conference, new developments related to the PARP inhibitor talazoparib in precision diagnosis and treatment were announced. Precision diagnosis has become a leading trend in the field of prostate cancer, and biomarker research is receiving increasing attention. In this context, this publication invited Professor Guiming Zhang from Qingdao University Affiliated Hospital, a well-known young expert in the field of prostate cancer, for an in-depth interview to explain the three new developments related to talazoparib's precision treatment recently announced at ESMO. Here, we provide a summary of the interview for the readers.
ESMO Exclusive Interview | Professor HuiyanLuo : Significant Efficacy of the Combination of Anti-PD-L1/TGF-βRII Dual-Target Antibody SHR-1701 with Bevacizumab in the Treatment of Advanced Solid Tumors

ESMO Exclusive Interview | Professor HuiyanLuo : Significant Efficacy of the Combination of Anti-PD-L1/TGF-βRII Dual-Target Antibody SHR-1701 with Bevacizumab in the Treatment of Advanced Solid Tumors

The 2023 European Society for Medical Oncology (ESMO) Annual Meeting took place from October 20th to 24th in Madrid, Spain. The Oncology Insights Reporting Team delved deep into the front lines to witness international advancements and to witness the progress of China's anti-tumor efforts on the global stage. Professor Huiyan Luo from Sun Yat-sen University Cancer Center presented a crucial oral presentation (Abstract ID: 1026MO) at this conference. In this on-site interview, Professor Huiyan Luo shared insights into the study of the treatment of advanced solid tumors using the dual-target antibody SHR-1701, which targets PD-L1 and TGF-βRII, in combination with the VEGF inhibitor bevacizumab, as well as her thoughts on future directions for the treatment of advanced tumors. This article compiles the relevant content for readers.
Advancing Breast Cancer Control in the Philippines: Insights from Professor Corazon Ngelangel at the CCHIO Congress

Advancing Breast Cancer Control in the Philippines: Insights from Professor Corazon Ngelangel at the CCHIO Congress

Professor Corazon Ngelangel, a leading medical oncologist, recently shared her valuable insights at the CCHIO Congress. Her discussion provided a comprehensive overview of the progress in breast cancer control over the past 30 years. Professor Ngelangel's expertise and experiences, particularly in the challenging times of the pandemic, underscored the significance of such international forums for knowledge exchange and collaboration
Revolutionizing Cancer Care: Dr. Tony Ng’s Pioneering Insights at the CCHIO Congress

Revolutionizing Cancer Care: Dr. Tony Ng’s Pioneering Insights at the CCHIO Congress

Dr. Tony Ng, a renowned figure in the field of cancer research, recently participated in the 10-Day HIV-Related Congress. This event was a gathering of top minds in medicine, featuring doctors, scientists, and researchers from over 30 districts in China. Dr. Ng's role as a speaker at this congress highlighted his significant contributions to cancer research and management.
The Role of Artificial Intelligence in Medicine: Insights from an Expert

The Role of Artificial Intelligence in Medicine: Insights from an Expert

In a recent interview, a renowned expert in the field of artificial intelligence (AI) and medicine provides valuable insights into their background, experience, and contributions. The discussion explores the impact of AI in the healthcare industry, the expert's involvement in shaping health reforms in China, their industry experience at IBM, and their role in advising and mentoring startups. This article offers a comprehensive overview of the dialogue, amplifying key points and perspectives shared by Dr. Dimitris Kalogeropoulos.